Nippon Shinyaku Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nippon Shinyaku Co Ltd with three other
companies in this sector in Japan:
Zeria Pharmaceutical Co Ltd
sales of 62.48 billion Japanese Yen [US$545.41 million]
of which 54%
was Pharmaceuticals Business),
Mochida Pharmaceutical Company Limited
(92.27 billion Japanese Yen [US$805.53 million]
Towa Pharmaceutical Company Limited
(82.12 billion Japanese Yen [US$716.86 million]
of which 100%
was Pharmaceutical Business).
During the year ended March of 2016, sales at
Nippon Shinyaku Co Ltd were ¥84.21 billion (US$735.14 million).
increase of 5.3%
versus 2015, when the company's sales were ¥79.99 billion.
This was the fifth consecutive year of sales increases at Nippon Shinyaku Co Ltd
(and since 2011, sales have increased a total of 33%).
Sales of Pharmaceutical Products saw an increase
6.3% in 2016, from
¥66.34 billion to ¥70.49 billion.